
    
      Clinical Study of phase I-II, controlled, simple blind (in relation with biostatistical
      analysis), randomized, of formulation that containing snail slime Helix aspersa MÃ¼ller
      (Cryptophalus aspersus), natural calendula extract, propolis and excipients (MU001).

      The formulation in study MU001 wil be added to the standard of care for healing in diabetic
      foot indicated. The period of recruitment estimated will be 4 month and the follow-up of the
      patients will be of until 60 days.
    
  